Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

That would be logical once the anecdotal reports

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
vidpok45 Member Profile
 
Followed By 15
Posts 2,539
Boards Moderated 0
Alias Born 06/15/10
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/17/2014 5:04:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/17/2014 5:03:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/17/2014 5:03:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/17/2014 5:02:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/17/2014 5:01:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/17/2014 5:00:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/17/2014 4:59:24 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/17/2014 4:58:30 PM
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results "Business Wire" - 7/16/2014 7:35:00 AM
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe "Business Wire" - 7/14/2014 7:35:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/27/2014 4:29:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/26/2014 6:02:16 AM
Amended Securities Registration (section 12(b)) (8-a12b/a) "Edgar (US Regulatory)" - 6/24/2014 4:55:54 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/24/2014 4:51:59 PM
ARIAD Announces Three Key Appointments to Its Global Management Team "Business Wire" - 6/23/2014 7:35:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 6/19/2014 4:43:54 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/19/2014 7:58:38 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 6/19/2014 7:54:47 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/17/2014 4:54:48 PM
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019 "Business Wire" - 6/12/2014 9:15:00 AM
ARIAD Announces Proposed $175 Million Offering of Convertible Senior Notes Due 2019 "Business Wire" - 6/11/2014 4:01:00 PM
ARIAD Announces Webcast of Its Annual Shareholders Meeting "Business Wire" - 6/11/2014 7:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/5/2014 4:06:47 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/4/2014 4:30:03 PM
ARIAD Announces Longer-Term Safety and Efficacy Data of Ponatinib from PACE and Phase 1 Clinical Trials "Business Wire" - 6/2/2014 7:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist